Valbiotis SA (EPA:ALVAL)

France · Delayed Price · Currency is EUR

1.070

-0.022 (-2.01%)

Apr 2, 2026, 5:35 PM CET

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Vitamins & Nutrition Products	905.00K	176.00K	4.73M	785.00K	298.00K
Vitamins & Nutrition Products Growth	414.20%	-96.28%	502.93%	163.42%	-90.36%
Total	905.00K	176.00K	4.73M	785.00K	298.00K
Total Growth	414.20%	-96.28%	502.93%	163.42%	-90.36%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
France	905.00K	176.00K	4.73M	785.00K	298.00K
France Growth	414.20%	-96.28%	502.93%	163.42%	-90.36%
Total	905.00K	176.00K	4.73M	785.00K	298.00K
Total Growth	414.20%	-96.28%	502.93%	163.42%	-90.36%

Source: S&P Global Market Intelligence.